Use of antipsychotic polypharmacy among patients with schizophrenia and risk of death

被引：0
|
作者：
Gasse, Christiane [1 ]
Baandrup, Lone [2 ]
Nordentoft, Merete [4 ]
Glenthoj, Birte Y. [2 ]
Lublin, Henrik [2 ]
Jensen, Vibeke Dahl [3 ]
Thomsen, Lars Krogsgaard [3 ]
Poulsen, Jan [3 ]
Mortensen, Preben B. [1 ]
机构：
[1] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark
[2] Copenhagen Univ Hosp, Fac Hlth Sci, Ctr Neuropsychiat Schizophrenia Res, Glostrup, Denmark
[3] Danish Med Agcy, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Psychiat, Bispebjerg, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
465
引用
收藏
页码：S204 / S205
页数：2
相关论文
共 50 条
  • [31] Antipsychotic Polypharmacy in Schizophrenia Benefits and Risks
    Barnes, Thomas R. E.
    Paton, Carol
    CNS DRUGS, 2011, 25 (05) : 383 - 399
  • [32] Causes of antipsychotic polypharmacy in schizophrenia treatment
    Ozalmete, Ozlem Albayrak
    Ozalmete, E. Onur
    Ceylan, M. Emin
    Sevim, Meltem Efe
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (01): : 68 - 74
  • [33] Cost of antipsychotic polypharmacy in the treatment of schizophrenia
    Baojin Zhu
    Haya Ascher-Svanum
    Douglas E Faries
    Christoph U Correll
    John M Kane
    BMC Psychiatry, 8
  • [34] Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
    Bighelli, Irene
    Rodolico, Alessandro
    Siafis, Spyridon
    Samara, Myrto T.
    Hansen, Wulf-Peter
    Salomone, Salvatore
    Aguglia, Eugenio
    Cutrufelli, Pierfelice
    Bauer, Ingrid
    Baeckers, Lio
    Leucht, Stefan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (08):
  • [35] Increased risk of fatal intoxication and polypharmacy among psychiatric patients at death
    Reuss, Christian Fyhn
    Hasselstrom, Jorgen Bo
    Linnet, Kristian
    Christoffersen, Dorte Jensen
    Leth, Peter Mygind
    Boel, Lene Warner Thorup
    Banner, Jytte
    JOURNAL OF FORENSIC SCIENCES, 2021, 66 (01) : 255 - 264
  • [36] Antipsychotic polypharmacy and early death - Reply
    Waddington, JL
    Youssef, HA
    Kinsella, A
    BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 368 - 369
  • [37] Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
    Schneeweiss, Sebastian
    Setoguchi, Soko
    Brookhart, Alan
    Dormuth, Colin
    Wang, Philip S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (05) : 627 - 632
  • [38] Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study
    Sneider, Benjamin
    Pristed, Sofie Gry
    Correll, Christoph U.
    Nielsen, Jimmi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (10) : 1669 - 1676
  • [39] QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy
    Elliott, Anja
    Mork, Thibault Johan
    Hojlund, Mikkel
    Christensen, Thomas
    Jeppesen, Rasmus
    Madsen, Nikolaj
    Viuff, Anne Grethe
    Hjorth, Peter
    Nielsen, Jens Cosedis
    Munk-Jorgensen, Povl
    CNS SPECTRUMS, 2018, 23 (04) : 278 - 283
  • [40] Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia
    Sim, K
    Su, A
    Fujii, S
    Yang, SY
    Chong, MY
    Ungvari, GS
    Si, TM
    Chung, EK
    Tsang, HY
    Chan, YH
    Heckers, S
    Shinfuku, N
    Tan, CH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (02) : 178 - 183
12345